Exporter Supply Landscape

Supplier countries for heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001

A reported trade view for HS 300190, with available observations through 2024.

HS6 300190Coverage 1995-2024Updated 2026-08-14
Explore this product

Leading supplier

China$786.1M

Supplier countries

193Reported suppliers

Top supplier reach

102Destination markets

Latest global trade

$3.6BYear: 2024

Reported observations

Supplier evidence

Supplier countries ranked by latest reported export value.

SupplierLatest exports5-year growthDestinationsLeading destination
China$786.1M-8.4%102USA
USA$647.7M+3.6%121Sweden
Singapore$432.1M-8.5%38Hungary
France$306.3M-10.9%92Singapore
Spain$243.0M+12.2%55France
Germany$175.7M+3.8%100Spain
Sweden$159.0M+3.9%26Belgium
Netherlands$128.9M-1.5%75France
Ireland$118.5M-2%30France
Italy$88.6M-3.5%67Spain
India$81.0M+39.8%134USA
Brazil$56.4M+0.1%62Spain
Republic of Korea$44.8M+11%76Russia
New Zealand$38.3M+22.4%27USA
Thailand$28.9M+21%22China
Poland$28.6M-8.4%26Spain
United Kingdom$26.0M-3.5%78USA
Argentina$23.5M+10.9%37USA
Switzerland, Liechtenstein$22.0M+6.6%78Italy
Belgium$18.7M-1.9%67Netherlands
Austria$18.5M+10.2%39Germany
Denmark$17.7M+13.2%69United Kingdom
Mexico$15.3M+68.8%28Italy
Costa Rica$15.3M+29.1%28USA
Canada$12.9M-6.4%52USA
Australia$11.9M+0.7%37Switzerland, Liechtenstein
Viet Nam$11.7M+81.6%12Switzerland, Liechtenstein
China, Hong Kong Special Administrative Region$5.8M+8.9%23Algeria
Czechia$5.5M+19.5%43Austria
Indonesia$4.8M+108.9%17China
Slovenia$4.5M+41.5%7Croatia
United Arab Emirates$4.4M+55.5%32Iran
Luxembourg$4.2M+27.6%8Sweden
Bulgaria$4.0M+28.4%16Spain
Portugal$3.7M-33.2%28China

Market reading

Which countries supply heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001?

China is the leading reported supplier in this view, with exports of $786.1M.

How to use this view

Start with the leading rows in the first table, then use the chart to compare supplier scale and destination reach for heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001. The second table adds a related reported comparison.

Coverage extends to 2024. Missing values are shown as not reported.

Further comparison

Supplier corridor unit-value evidence

Reported corridor unit values for the selected supplier, compared with each buyer market's median.

Buyer marketReported yearTrade valueQuantityUnit value USD/tonBuyer-market median USD/ton
USA2023$156.8M1,788.2 t$87,683.76$895,487.32
China, Hong Kong Special Administrative Region2023$122.3M19.5 t$6,268,797.88$509,000
Spain2023$92.1M20.9 t$4,407,043.35$199,041.1
Italy2023$72.0M11.8 t$6,110,446.17$2,435,726.31
Germany2023$69.7M8.9 t$7,812,858.92$247,593.33
Turkey2023$59.7M4.8 t$12,415,851.8$276,000
India2023$40.3M43.7 t$922,311.83$801,111.11
France2023$36.9M88.9 t$415,089.9$270,000
Japan2023$26.4M227.9 t$115,677.67$1,278,072.29
Portugal2023$17.8M1.4 t$13,171,477.1$209,712.61
Netherlands2023$17.1M60.2 t$283,703.61$1,105,203.36
Mexico2023$16.4M6.8 t$2,417,981.24$1,440,000
Russia2023$15.9M144.3 t$109,944.34$457,079.94
Cambodia2023$15.4M7.3 t$2,102,992.07$670,400
Republic of Korea2023$14.2M10.4 t$1,372,640.45$58,142.86
Argentina2023$9.4M0.6 t$17,010,235.08$903,404.26
Colombia2023$9.1M20.1 t$452,690.51$755,000
Belgium2023$9.0M0.6 t$16,287,852.99$164,500
Tunisia2023$8.7M0.6 t$14,331,095.71$1,563,333.33
Norway2023$7.9M0.4 t$17,855,605.44$886,714.29

Explore related views

Continue with another perspective on this product.

Latest observed year: 2024. Page updated 2026-08-14.

Source and date

Reported merchandise-trade observations for HS6 products. Coverage shown on this page: 1995-2024. Updated 2026-08-14.

Definitions

Trade value is reported in current US dollars. Unit value is trade value divided by reported quantity and is shown per metric ton where available. Growth is an annualized or year-on-year calculation from reported values.

Reading the data

“Not reported” means a value was not available for this view. Values can be revised as reporting is updated. See the methodology for coverage and classification details.